3 unknown. 3 Phase 1, 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 3 | Unknown 3 |
| Phase 2 | 2 | Unknown 2 |
Follow PD-1: new trials by email Literature Review of PD-1 trials Research Report on PD-1
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Safety, Tolerability, and Efficacy of GLS-012 and GLS-010 in Patients With Advanced Non-Small Cell Lung Cancer GLS-012+GLS-010, GLS-012+GLS-010+pemetrexed+carboplatin, GLS-012+GLS-010+paclitaxel+carboplatin - Advanced Non-Small Cell Lung Cancer | Phase 1 / Phase 2 | Unknown | Guangzhou Gloria Biosciences Co., Ltd. | 152 | 2023-08-10 | 2023-08-07 |
| Clinical Study of a Personalized Neoantigen Cancer Vaccine Combined With Anti-PD-1 and RFA in Patients With Solid Tumors iNeo-Vac-P01, GM-CSF, PD-1 - Advanced Malignant Solid Tumor | Phase 1 | Unknown | Sir Run Run Shaw Hospital | 30 | 2020-09-03 | 2021-04-28 |
| Toripalimab With Preoperative Chemoradiotherapy for LA-EGJ PD-1 - PD-1, Chemoradiotherapy | Phase 1 / Phase 2 | Unknown | Peking University | 45 | 2019-08-26 | 2019-08-20 |
Guangzhou Gloria Biosciences Co., Ltd. (1) · Peking University (1) · Sir Run Run Shaw Hospital (1)
China (2)
Yongheng Li, MD (1) · Ziyu Li, MD (1)